Initial experience with high‐volume plasma exchange in patients with acute liver failure
Journal of Clinical Apheresis · 2021-06 · 36 (3) · 379-389
DOI: 10.1002/jca.21873 ↗At a glance
Journal article in Journal of Clinical Apheresis, published online on 2021-01-05. Written by Ji Eun Kim and 9 co-authors. Institution: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Cited 21 times so far (Crossref); 26 references.
Abstract (original language)
Background/Aims High‐volume plasma exchange (HVPE), defined as an exchange of 8 to 12 L per day per procedure or 15% of the ideal body weight with fresh frozen plasma, has shown promising results in improving the survival of patients with acute liver failure (ALF). However, clinical evidence is limited. The aim of this study was to report our initial experience using HVPE as a bridge treatment in patients with ALF.
Methods
We retrospectively reviewed 32 consecutive patients awaiting liver transplantation (LT) due to ALF between 2013 and 2020 at Samsung Medical Center in Korea. HVPE has been used for patients with ALF since May 2016 at our institution.
Results
During the study period, 16 patients received HVPE. After HVPE, coagulopathies (INR, 4.46 [2.32‐6.02] vs 1.48 [1.33‐1.76], P < .05), total bilirubin (22.6 [9.1‐26.4] vs 8.9 [5.6‐11.3], P < .05), alanine aminotransferase (506 [341‐1963] vs 120 [88‐315], P < .05), and ammonia levels (130.6 [123.7‐143.8] vs 98.2 [84.2‐116.5], P < .05) were improved. Improvement in the hepatic encephalopathy grade was observed in four patients. Among 16 patients who received HVPE, 12 patients were bridged to LT, and three patients recovered spontaneously. The overall survival was 94% and 69%, respectively at 30 days in patients who received and did not receive HVPE ( P = .068). Among 18 patients with high chronic liver failure‐sequential organ failure assessment scores (≥13), the overall survival was significantly better for those who received HVPE than for those who did not (91% vs 29%, respectively, at 30 days, P < .05).
Conclusions
Our initial clinical experience with HVPE suggests that HVPE can be a viable option in improving the outcomes of patients presenting with ALF.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Laboratory Medicine, Chonnam National University Medical School & Hospital, Gwangju, South Korea.
- Heathdrim local clinics, Pyeongtaek-si, South Korea.
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
ORCID profiles: Dong Hyun Sinn
Cite
APA
Kim, J. E., Chun, S., Sinn, D. H., Kim, N. J., Kim, S., Kang, W., Kim, J. M., Choi, G. S., Joh, J. W., & Cho, D. (2021). Initial experience with high‐volume plasma exchange in patients with acute liver failure. Journal of Clinical Apheresis, 36(3), 379-389. https://doi.org/10.1002/jca.21873
Vancouver
Kim JE, Chun S, Sinn DH, Kim NJ, Kim S, Kang W, et al. Initial experience with high‐volume plasma exchange in patients with acute liver failure. Journal of Clinical Apheresis. 2021;36(3):379-389. doi:10.1002/jca.21873
BibTeX
@article{Kim2021,
author = {Kim, Ji Eun and Chun, Sejong and Sinn, Dong Hyun and Kim, Nam Joong and Kim, Semi and Kang, Wonseok and Kim, Jong Man and Choi, Gyu-Seong and Joh, Jae-Won and Cho, Duck},
title = {Initial experience with high‐volume plasma exchange in patients with acute liver failure},
journal = {Journal of Clinical Apheresis},
year = {2021},
volume = {36},
number = {3},
pages = {379--389},
doi = {10.1002/jca.21873}
}
EUVIMED